Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...
HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 Signals of dose-dependent reduction in active reservoir, and viral ...
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
“No new HIV diagnoses should occur when we have medication today to stop the transmission of that disease.” David Ramos, Cascade Aids Project public policy manager, testified for the bill ...
The US government's sudden decision to axe funding for HIV programmes is a "wake-up call ... the head of the Africa Centres for Disease Control and Prevention (Africa CDC) issued a stark warning ...
New research has revealed that using artificial intelligence (AI) to analyse photos taken during routine diabetes eye screenings can predict whether people with type 2 diabetes are likely to develop ...
The “ripple effects” of President Donald Trump’s bid to shutter the agency are already being felt around the world, current ...
“This led me to contracting many serious illnesses like tuberculosis and skin diseases.” Mercy was placed on HIV treatment, giving her a lifeline, but recent news on the freeze order has her s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results